doi: 10.23937/2378-3656/1410150 Summary Keywords euglycemic diabetic ketoacidosis (euDKA), SGLT-2 inhibitor, GLP-1 receptor agonist, type 2 diabetes mellitus, adverse drug reaction Citation Gandecka-Pempera A, Naskrt D, Adamska A and Zozuliska-Zikiewicz D (2025) Severe euglycemic ketoacidosis following combined therapy with GLP-1 receptor agonist and SGLT-2 inhibitor, refractory to standard treatment: a case report
This led to the idea of using GLP-1 analogs for weight reduction
By making smart dietary choices, staying hydrated, eating smaller meals, and using medications or supplements as needed, you can minimize this side effect while continuing to shed excess pounds and focus on the benefits of your treatment
Smith DL Jr, Nagy TR, Allison DB
Win free shipping Buy 2 or more to avail
Tsuda T, Ueno Y, Yosikawa T, Kojo H, Osawa T